echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > EULAR Recommendation: Core Data Set for Pregnancy Registration of Rheumatism

    EULAR Recommendation: Core Data Set for Pregnancy Registration of Rheumatism

    • Last Update: 2021-12-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In recent years, several rheumatism pregnancy registries have been established in Europe to prospectively collect and analyze data on pregnant women with different inflammatory rheumatism (IRD)


    The European Union Against Rheumatism (EULAR) Working Group on Antirheumatic Drugs in Pregnancy and Lactation also emphasized the need to cooperate in collating data on new drugs

    The combined analysis of data from different sources requires that the collected data have a certain degree of homogeneity


    Research design As emphasized by other initiatives in rheumatology, coordination and standardization of projects and their cross-research measurements are essential to promote collaborative research


    , These studies prospectively collect information about pregnant women with IRD, including the neonatal stage (4 weeks postpartum)

    Method: A step-by-step process includes two rounds of Delphi surveys and a face-to-face meeting to reach consensus on related projects


    Method: consensus

    Results: A total of 64 multidisciplinary stakeholders from 14 different countries participated in the two rounds of the Delphi process


    Result: Rheumatoid Arthritis

    In summary, this is the first consensus-based core data set for prospective pregnancy registration in rheumatology


    This is the first consensus-based core data set for prospective pregnancy registration in rheumatology
    .
    Its purpose is to promote and promote transnational cooperation, aiming to increase the understanding of the pregnancy process and the safety of treatment for women with IRD during pregnancy
    .
    It is hoped that this proposal will be helpful in establishing a new registry and increase the willingness of rheumatologists, other healthcare professionals and patients to contribute to the registry and provide the necessary data
    .


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.